PharmacoEconomics & Outcomes News 784, p10 - 12 Aug 2017
Costs of diabetic ketoacidosis
high in UK
Costs for the management of episodes of diabetic
ketoacidosis are relatively high in the UK, according to
findings of a study published in Diabetic Medicine.
Data for 283 admissions in 281 adults with diabetic
ketoacidosis attending hospitals in the UK who
completed a national survey in 2014 were used to assess
resource use and total costs associated with the
treatment of diabetic ketoacidosis. All patients received
intravenous insulin hourly until resolution of
ketoacidosis. It was assumed that except for up to
four hours in the emergency department initially,
patients were treated in a high dependency unit or
intensive care unit. Societal costs and costs of
comorbidities were excluded.
The mean duration of hospitalisation per episode of
diabetic ketoacidosis was 5.6 days, the mean time to
resolution of ketoacidosis was 22.3h, and the average
cost per episode was £2064 per patient.
"Given the many assumptions made it is likely that the
true costs of an episode of diabetic ketoacidosis are
much higher," commented the authors. "These data
should be used to enable funders to plan for future costs
associated with this potentially life-threatening medical
emergency," they said.
Dhatariya KK, et al. The cost of treating diabetic ketoacidosis in the UK: a
national survey of hospital resource use. Diabetic Medicine : 20 Jul 2017.
Available from: URL: http://doi.org/10.1111/dme.13427
PharmacoEconomics & Outcomes News 12 Aug 2017 No. 7841173-5503/17/0784-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved